aXichem AB Class A (AXIC.A) AI Stock Analysis

Top Page

aXichem AB Class A

(Nasdaq OMX AB:AXIC.A)

Select Model

Rating:43Neutral

Price Target:SEK 1.50▼(-14.53% Downside)

Action:reiterated

Date:10/27/26

The score is primarily held down by very weak financial performance (deep losses, negative gross profit, and sustained cash burn) and bearish technicals (price below key moving averages with negative MACD). The balance sheet’s low leverage provides some support, but valuation remains unfavorable due to ongoing losses and no indicated dividend yield.

Positive Factors

Low Financial LeverageThe modest debt burden and predominantly equity-funded asset base reduce near-term solvency pressure. This gives aXichem greater flexibility to pursue product development and commercialization while limiting the immediate drag from interest obligations and refinancing needs.

Negative Factors

Declining Revenue and Deep LossesThe combination of lower trailing revenue, negative gross profit, and an exceptionally deep net margin shows that the current business has not yet established sustainable economics. Continued losses reduce internal funding capacity and make future growth dependent on a meaningful improvement in sales and profitability.

aXichem AB Class A (AXIC.A) vs. iShares MSCI Sweden ETF (EWD)

Market Cap: SEK 133.98M
Dividend Yield: ―
Average Volume (3M): 70.15K
Price to Earnings (P/E): -7.0
Beta (1Y): 0.12
Revenue Growth: 36.35%
EPS Growth: 38.34%
Country: Sweden
Employees: 7
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals - Specialty

aXichem AB Class A Business Overview & Revenue Model

Company Description

aXichem AB is a biotechnology firm, established in 2007 and headquartered in Malmö, Sweden, that specializes in creating natural analogue compounds. The company offers aXivite, a capsaicin analogue solution designed for various dietary health applica...

How the Company Makes Money

aXichem makes money primarily by commercializing its phenylcapsaicin-based products (notably aXiphen®) and monetizing its underlying intellectual property. Revenue is generated through (1) sales of product to the market (typically via distributors/pa...

aXichem AB Class A Financial Statement Overview

Summary

Overall fundamentals are weak: revenue declined (~13.9% TTM), profitability is deeply negative (negative gross profit and ~-95% net margin), and cash burn is persistent (TTM operating cash flow ~-8.0m; free cash flow ~-8.8m). The key offset is a comparatively solid balance sheet with low leverage (~0.6m debt vs ~55.2m equity), which supports solvency despite ongoing losses.

Income Statement

18Very Negative

Balance Sheet

62Positive

Cash Flow

24Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	16.27M	18.45M	8.57M	1.81M	5.01M	4.36M
Gross Profit	1.99M	-14.51M	7.08M	1.41M	3.82M	909.00K
EBITDA	-10.20M	-12.04M	-11.55M	-13.48M	-11.03M	-12.58M
Net Income	-15.51M	-17.63M	-17.81M	-20.81M	-17.26M	-15.09M
Balance Sheet
Total Assets	59.46M	61.09M	74.28M	61.49M	61.25M	58.77M
Cash, Cash Equivalents and Short-Term Investments	2.87M	3.08M	14.36M	4.31M	6.55M	9.45M
Total Debt	595.00K	4.73M	0	10.27M	18.76M	0
Total Liabilities	4.19M	8.22M	4.13M	12.96M	20.92M	2.47M
Stockholders Equity	55.25M	52.86M	70.13M	48.51M	40.31M	56.30M
Cash Flow
Free Cash Flow	-8.78M	-16.00M	-11.50M	-15.68M	-21.71M	-20.32M
Operating Cash Flow	-7.95M	-11.35M	-11.50M	-15.68M	-19.10M	-15.60M
Investing Cash Flow	-2.81M	-4.66M	-6.50M	-5.10M	-2.61M	-4.73M
Financing Cash Flow	6.85M	4.73M	28.05M	18.54M	18.80M	17.73M

aXichem AB Class A Technical Analysis

Technical Analysis SentimentNegative

Last Price1.75

Price Trends

50DMA1.98Negative

100DMA2.24Negative

200DMA1.84Negative

Market Momentum

MACD-0.08Positive

RSI40.22Neutral

STOCH30.67Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AXIC.A, the sentiment is Negative. The current price of 1.75 is below the 20-day moving average (MA) of 1.84, below the 50-day MA of 1.98, and below the 200-day MA of 1.84, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 40.22 is Neutral, neither overbought nor oversold. The STOCH value of 30.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:AXIC.A.

aXichem AB Class A Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

SE:AXIC.A against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:HPOL.B	68Neutral	SEK 31.74B	17.55	12.33%	4.56%	-0.82%	-7.46%
SE:PCAT	65Neutral	SEK 14.87M	4.56	―	―	-17.14%	88.76%
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
SE:ORGC	45Neutral	SEK 83.91M	-1.52	-176.65%	―	-21.95%	-28.77%
SE:POLYG	44Neutral	SEK 85.47M	-19.61	-1.52%	―	-18.26%	35.77%
SE:AXIC.A	43Neutral	SEK 133.98M	-7.04	-27.51%	―	36.35%	38.34%
SE:NEXAM	38Underperform	SEK 258.28M	-12.35	-9.37%	―	-4.57%	-15.20%

* Basic Materials Sector Average

Performance Comparison

SE:AXIC.A and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
SE:AXIC.A	aXichem AB Class A	1.75	-0.97	-35.48%
SE:HPOL.B	Hexpol AB	92.15	11.61	14.42%
SE:NEXAM	Nexam Chemical Holding AB	2.52	-0.60	-19.23%
SE:POLYG	Polygiene AB	2.34	-7.06	-75.11%
SE:ORGC	OrganoClick AB	0.46	-1.42	-75.64%
SE:PCAT	Photocat A/S	2.48	-2.32	-48.33%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 27, 2026

aXichem AB Class A AI Stock Analysis

Top Page